Without clear timelines and accountability, Ireland risks falling short of its goal to end new HIV transmissions by 2030.
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.
But he agreed that countries need to own and operate their own AIDS responses. HIV/AIDS experts are thinking through the logistics and timeline of the rollout with the hope that drugs could make it to ...
Indian generic manufacturers will produce lenacapavir, a near 100% effective, six-month injectable HIV prevention drug, ...
Khaleej Times on MSN
HIV-prevention drug to be available for $40 a year from 2027
The two organisations have entered into separate agreements with Indian pharmaceutical companies to produce cheaper generic ...
A game-changer in HIV prevention. moses sagwe26 September 2025 - 14:54 ...
The United Nations agency focusing on the HIV/AIDS pandemic could close by the end of next year as the U.N. restructures in ...
TB/HIV patients with advanced HIV disease can be successfully managed in integrated TB/HIV MoH clinics in rural Kenya. Treatment outcomes improve with time, likely reflecting a variety of factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback